Financial statements Medi Pharma
Balance sheet data of MEDI PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 392 265,18 | 271 817,27 | 230 624,23 | 272 187,88 | 293 104,52 |
| A. Fixed assets | 791,65 | 291,65 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 391 473,53 | 271 525,62 | 230 624,23 | 272 187,88 | 293 104,52 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 392 265,18 | 271 817,27 | 230 624,23 | 272 187,88 | 293 104,52 |
| A. Equity | -61 606,11 | -51 327,34 | -30 443,66 | -955,27 | 197 954,53 |
| B. Liabilities and provisions for liabilities | 453 871,29 | 323 144,61 | 261 067,89 | 273 143,15 | 95 149,99 |
| I. Long-term liabilities | 0,00 | - | - | - | - |
| II. Short-term liabilities | 453 871,29 | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.